4.7 Review

Micro- and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care

Journal

MICROCHIMICA ACTA
Volume 189, Issue 2, Pages -

Publisher

SPRINGER WIEN
DOI: 10.1007/s00604-022-05171-2

Keywords

Cytokine; Blood pathogen; Biosensor; Infection; Sepsis care; Procalcitonin; Lactate; Bacteremia

Funding

  1. Instituto de Salud Carlos III [PI20/0538, CD19/00140]
  2. European Union (ERDF, A way to make Europe)
  3. IdISBa/Impost turisme sostenible/Agencia d'Estrategia Turistica de les Illes Balears/Govern de les Illes Balears. A. Alba-Patino: Stop fuga de cerebros Fellowship (Roche)

Ask authors/readers for more resources

This article reviews recent advances in diagnostic tools for managing sepsis based on micro- and nanostructured materials. It discusses popular biomarkers and detection methods for sepsis diagnosis, and highlights the role of micro- and nanostructured materials in developing biosensors to meet the specific needs of different points of sepsis care. The article also summarizes the most utilized materials and points out future challenges for development.
Severe infections can cause a dysregulated response leading to organ dysfunction known as sepsis. Sepsis can be lethal if not identified and treated right away. This requires measuring biomarkers and pathogens rapidly at the different points where sepsis care is provided. Current commercial approaches for sepsis diagnosis are not fast, sensitive, and/or specific enough for meeting this medical challenge. In this article, we review recent advances in the development of diagnostic tools for sepsis management based on micro- and nanostructured materials. We start with a brief introduction to the most popular biomarkers for sepsis diagnosis (lactate, procalcitonin, cytokines, C-reactive protein, and other emerging protein and non-protein biomarkers including miRNAs and cell-based assays) and methods for detecting bacteremia. We then highlight the role of nano- and microstructured materials in developing biosensors for detecting them taking into consideration the particular needs of every point of sepsis care (e.g., ultrafast detection of multiple protein biomarkers for diagnosing in triage, emergency room, ward, and intensive care unit; quantitative detection to de-escalate treatment; ultrasensitive and culture-independent detection of blood pathogens for personalized antimicrobial therapies; robust, portable, and web-connected biomarker tests outside the hospital). We conclude with an overview of the most utilized nano- and microstructured materials used thus far for solving issues related to sepsis diagnosis and point to new challenges for future development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available